Avrupa Birliği -
Estonca -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - südamepuudulikkus - angiotensiin ii antagonistidega, muud kombinatsioonid, toimivad ained renin-angiotensiini süsteemi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Avrupa Birliği -
Estonca -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - südamepuudulikkus - reniini-angiotensiini süsteemi toimivad ained - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
Avrupa Birliği -
Estonca -
EMA (European Medicines Agency)
imprida
novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - hüpertensioon - reniini-angiotensiini süsteemi toimivad ained - essentsiaalse hüpertensiooni ravi. imprida on näidustatud patsientidele, kelle vererõhk ei ole adekvaatselt kontrollitav kohta amlodipine või valsartan monotherapy.
Estonya -
Estonca -
Ravimiamet
suvartar hct 80 mg/12,5 mg õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 80mg+12,5mg 90tk; 80mg+12,5mg 28tk; 80mg+12,5mg 98tk; 80mg+12,5mg 20tk; 80mg+12,5mg 280tk; 80mg+12,5mg 30tk; 80mg+12,5mg 100tk; 80mg+12,5mg 15tk; 80mg+12,5mg 56tk; 80mg+12,5mg 7tk; 80mg+12,5mg 10tk; 80mg+12,5mg 50tk; 80mg+12,5mg 60tk
Estonya -
Estonca -
Ravimiamet
valzap h õhukese polümeerikattega tablett
zentiva k.s. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 80mg+12,5mg 84tk; 80mg+12,5mg 90tk; 80mg+12,5mg 30tk; 80mg+12,5mg 14tk; 80mg+12,5mg 98tk; 80mg+12,5mg 56tk
Estonya -
Estonca -
Ravimiamet
valsacombi õhukese polümeerikattega tablett
krka, d.d., novo mesto - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 160mg+12,5mg 60tk; 160mg+12,5mg 84tk; 160mg+12,5mg 90tk
Estonya -
Estonca -
Ravimiamet
valsacombi õhukese polümeerikattega tablett
krka, d.d., novo mesto - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 320mg+25mg 84tk; 320mg+25mg 30tk; 320mg+25mg 28tk; 320mg+25mg 56tk; 320mg+25mg 60tk; 320mg+25mg 280tk; 320mg+25mg 100tk
Estonya -
Estonca -
Ravimiamet
valsacombi õhukese polümeerikattega tablett
krka, d.d., novo mesto - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 80mg+12,5mg 56tk; 80mg+12,5mg 98tk; 80mg+12,5mg 60tk; 80mg+12,5mg 84tk; 80mg+12,5mg 90tk; 80mg+12,5mg 28tk
Estonya -
Estonca -
Ravimiamet
valsacombi õhukese polümeerikattega tablett
krka, d.d., novo mesto - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 160mg+25mg 56tk; 160mg+25mg 28tk; 160mg+25mg 280tk; 160mg+25mg 14tk; 160mg+25mg 90tk; 160mg+25mg 30tk
Estonya -
Estonca -
Ravimiamet
suvartar hct 160 mg/12,5 mg õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 160mg+12,5mg 50tk; 160mg+12,5mg 7tk; 160mg+12,5mg 100tk; 160mg+12,5mg 98tk; 160mg+12,5mg 30tk; 160mg+12,5mg 10tk; 160mg+12,5mg 280tk; 160mg+12,5mg 60tk; 160mg+12,5mg 84tk; 160mg+12,5mg 14tk; 160mg+12,5mg 15tk; 160mg+12,5mg 28tk; 160mg+12,5mg 56tk; 160mg+12,5mg 20tk